InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Stockwell Lynn. Director active across 3 companies, notably Bright Green Corp. Cumulatively, 7 filings have been published. Split: 3 buys · 1 sell. Total volume traded: €331k. Activity tracked since 30 May 2023. The latest transaction was disclosed on 5 June 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Stockwell Lynn is a declarant linked to Bright Green Corp, where he is Director, and to Drugs Made In America Acquisition Corp. and Drugs Made In America Acquisition II Corp., where he is CEO and Exe. Chair of Board. He has 7 filings in total, and among the sampled recent filings, they cover the period from 2023-06-01 to 2025-10-01, with 0 in buys and 330773 in sells.